The first case of cutaneous mucormycosis caused by Rhizopus azygosporus

被引:19
作者
Fujimoto, A [1 ]
Nagao, K
Tanaka, K
Yamagami, J
Udagawa, SI
Sugiura, M
机构
[1] Shizuoka Municipal Shimizu Hosp, Dept Dermatol, Shizuoka, Japan
[2] Keio Univ, Sch Med, Dept Dermatol, Shinjuku Ku, Tokyo 1608582, Japan
[3] Japan Food Res Inst, Tama Lab, Tokyo, Japan
关键词
amphotericin B; cutaneous; leg ulcer; minimum inhibitory concentration; mucormycosis; Rhizopus azygosporus;
D O I
10.1111/j.1365-2133.2005.06593.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A rapidly enlarging leg ulcer appeared in a 54-year-old woman with systemic lupus erythematosus receiving aggressive immunosuppressive therapy. Skin biopsy revealed proliferation of hyphae in the midst of a neutrophilic abscess. Culture yielded Rhizopus azygosporus. As no organ involvement was detected by thorough examination, the patient was diagnosed as having primary cutaneous mucormycosis. Although intravenous amphotericin B therapy seemed to be very effective, it had to be discontinued due to nephrotoxicity. She unfortunately died of subsequent disseminated fungal infection and cerebral infarction in which the primary cause could not be determined. Minimum inhibitory concentrations of several antifungal drugs to the isolate were examined and amphotericin B proved to be the only agent that may potentially reach the effective plasma concentration. This is the first case report of cutaneous mucormycosis caused by R. azygosporus.
引用
收藏
页码:428 / 430
页数:3
相关论文
共 9 条
[1]   AmBisome (Liposomal amphotericin B): A comparative review [J].
Boswell, GW ;
Buell, D ;
Bekersky, I .
JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (07) :583-592
[2]  
Kobayashi M, 2001, MYCOSES, V44, P311, DOI 10.1111/j.1439-0507.2001.00642.x
[3]  
KWONCHUNG KJ, 1992, MED MYCOL, P525
[4]  
NAGAO K, IN PRESS GENETIC IDE
[5]  
Schipper MAA, 1996, J MED VET MYCOL, V34, P199
[6]   In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model [J].
Sun, QN ;
Najvar, LK ;
Bocanegra, R ;
Loebenberg, D ;
Graybill, JR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) :2310-2312
[7]   Mucormycosis (Zygomycosis) in a heart-kidney transplant recipient:: Recovery after posaconazole therapy [J].
Tobón, AM ;
Arango, M ;
Fernández, D ;
Restrepo, A .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (11) :1488-1491
[8]   MUCORMYCOSIS OF THE NEONATAL GUT - A NEW DISEASE OR A VARIANT OF NECROTIZING ENTEROCOLITIS [J].
WOODWARD, A ;
MCTIGUE, C ;
HOGG, G ;
WATKINS, A ;
TAN, H .
JOURNAL OF PEDIATRIC SURGERY, 1992, 27 (06) :737-740
[9]  
YUAN GF, 1984, MYCOTAXON, V20, P397